SLC10A6
Sodium-dependent organic anion transporter
Also known as: SOAT, SOAT_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q3KNW5
- Gene
- SLC10A6
- Ensembl
- ENSG00000145283
- Chromosome
- 4
- Canonical length
- 377 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
Predicted to enable bile acid:sodium symporter activity. Predicted to be involved in bile acid and bile salt transport. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
377 residues, UniProt reviewed canonical sequence.
>Q3KNW5|SLC10A6
1 MRANCSSSSA CPANSSEEEL PVGLEVHGNL ELVFTVVSTV MMGLLMFSLG CSVEIRKLWS
61 HIRRPWGIAV GLLCQFGLMP FTAYLLAISF SLKPVQAIAV LIMGCCPGGT ISNIFTFWVD
121 GDMDLSISMT TCSTVAALGM MPLCIYLYTW SWSLQQNLTI PYQNIGITLV CLTIPVAFGV
181 YVNYRWPKQS KIILKIGAVV GGVLLLVVAV AGVVLAKGSW NSDITLLTIS FIFPLIGHVT
241 GFLLALFTHQ SWQRCRTISL ETGAQNIQMC ITMLQLSFTA EHLVQMLSFP LAYGLFQLID
301 GFLIVAAYQT YKRRLKNKHG KKNSGCTEVC HTRKSTSSRE TNAFLEVNEE GAITPGPPGP
361 MDCHRALEPV GHITSCELocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC10A6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 9
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- skin: 12 nTPM
- esophagus: 8.5 nTPM
- adipose tissue: 4.8 nTPM
- vagina: 4.3 nTPM
- testis: 3.7 nTPM
- cervix: 3.4 nTPM
Single-cell type
- late spermatids: 322 nCPM
- suprabasal keratinocytes: 117 nCPM
- early spermatids: 94 nCPM
- esophageal apical cells: 80 nCPM
- basal keratinocytes: 51 nCPM
- endometrial luminal cells: 44 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 2.4 nTPM
- white matter: 1.7 nTPM
- hypothalamus: 1.2 nTPM
- pons: 1 nTPM
- basal ganglia: 0.8 nTPM
- cerebral cortex: 0.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.55
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.1
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bile acid and bile salt transport
- transmembrane transport
- sodium-dependent organic anion transport
Molecular functions
- bile acid:sodium symporter activity
- sodium-dependent organic anion transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC10A6 as an antibody target. Whether an autoantibody or antibody against SLC10A6 could matter depends on whether native SLC10A6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC10A6 is annotated at the cell surface, where native SLC10A6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC10A6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...